MOH — authorised 19 September 1996
- Marketing authorisation holder: CONCORDIA PHARMS INC
- Status: likely_approved
🇮🇱 Nilandron in Israel
MOH authorised Nilandron on 19 September 1996
Marketing authorisation
Nilandron in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Nilandron approved in Israel?
Yes. MOH authorised it on 19 September 1996.
Who is the marketing authorisation holder for Nilandron in Israel?
CONCORDIA PHARMS INC holds the Israeli marketing authorisation.